Xizeng Zong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xizeng Zong has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Changhai Ding
Clinical Research Centre, Zhujiang Hospital Southern Medical University Guangzhou Guangdong China
2 shared publications Jianwei Zhu
Department of Orthopedics, School of Medicine The Second Affiliated Hospital of South China University of Technology (Guangzhou First People's Hospital) Guangzhou Guangdong China
2 shared publications- Simin Wen
Department of Orthopedics, Guangzhou First People's Hospital Guangzhou Medical University Guangzhou China
2 shared publications - Siqi Xu
Clinical Research Centre, School of Medicine, the Second Affiliated Hospital of South China University of Technology (Guangzhou First People’s Hospital), Guangzhou 510180, China
2 shared publications Guangfeng Ruan
Clinical Research Centre, School of Medicine The Second Affiliated Hospital of South China University of Technology (Guangzhou First People's Hospital) Guangzhou Guangdong China
1 shared publication- Guangfeng Ruan
Clinical Research Centre, Guangzhou First People’s Hospital, South China University of Technology, Guangzhou, China
1 shared publication
Latest Publications
- Open Access
- 31 August 2026
- Published by Wiley in Aging Cell
- Vol. 25 (9) , e70690
Integrative Analysis Uncover the Effects and Multi‐Omics Features of Thigh Muscle Fat Infiltration
The health impacts and underlying biological pathways of thigh muscle fat infiltration (TMFI) remain incompletely understood. In this study, we analyzed TMFI measured by magnetic resonance imaging in 55,120 UK Biobank participants and found that higher TMFI was significantly associated with all‐cause mortality as well as with all major system‐specific diseases examined ( p values ranged from 2.50 × 10 −88 to 9.97 × 10 −04 ). TMFI also mediated the effects of lifestyle factors on health‐related outcomes, with mediation proportions ranging from 6.7% to 71.7%. A genome‐wide association study (GWAS) identified 79 lead single nucleotide polymorphisms (SNPs) linked to TMFI, and the polygenic risk score for TMFI was significantly associated with mortality and all incident diseases across examined organ systems in an independent subset of UK Biobank participants of European ancestry who were not included in the TMFI GWAS ( n = 362,286, all p < 0.05). Gene–drug interactions identified multiple drugs that could potentially modulate TMFI. Analysis of single‐cell transcriptomic data indicated that myogenic cells were strongly linked to TMFI ( p = 7.08 × 10 −08 ). Summary‐data‐based Mendelian randomization and Transcriptome‐Wide Association Study analyses revealed numerous genes whose expression in specific tissues was associated with TMFI. Proteomic and metabolomic profiling uncovered a broad array of circulating biomarkers associated with TMFI, many of which mediated the effects of modifiable factors and genetic risk on TMFI. Overall, our results highlight the biological relevance of TMFI to human health and provide insights into the multi‐omics mechanisms underlying TMFI, identifying potential targets for interventions.
- 31 August 2026
- Published by Wiley in Aging Cell
- Vol. 25 (9) , e70690
Open AccessIntegrative Analysis Uncover the Effects and Multi‐Omics Features of Thigh Muscle Fat Infiltration
The health impacts and underlying biological pathways of thigh muscle fat infiltration (TMFI) remain incompletely understood. In this study, we analyzed TMFI measured by magnetic resonance imaging in 55,120 UK Biobank participants and found that higher TMFI was significantly associated with all‐cause mortality as well as with all major system‐specific diseases examined ( p values ranged from 2.50 × 10 −88 to 9.97 × 10 −04 ). TMFI also mediated the effects of lifestyle factors on health‐related outcomes, with mediation proportions ranging from 6.7% to 71.7%. A genome‐wide association study (GWAS) identified 79 lead single nucleotide polymorphisms (SNPs) linked to TMFI, and the polygenic risk score for TMFI was significantly associated with mortality and all incident diseases across examined organ systems in an independent subset of UK Biobank participants of European ancestry who were not included in the TMFI GWAS ( n = 362,286, all p < 0.05). Gene–drug interactions identified multiple drugs that could potentially modulate TMFI. Analysis of single‐cell transcriptomic data indicated that myogenic cells were strongly linked to TMFI ( p = 7.08 × 10 −08 ). Summary‐data‐based Mendelian randomization and Transcriptome‐Wide Association Study analyses revealed numerous genes whose expression in specific tissues was associated with TMFI. Proteomic and metabolomic profiling uncovered a broad array of circulating biomarkers associated with TMFI, many of which mediated the effects of modifiable factors and genetic risk on TMFI. Overall, our results highlight the biological relevance of TMFI to human health and provide insights into the multi‐omics mechanisms underlying TMFI, identifying potential targets for interventions.
- 1 February 2025
- Published by Wolters Kluwer Health in Hypertension
- Vol. 82 (2) , 333-346
Identification of Circulating Proteins Associated With Blood Pressure
BACKGROUND: Circulating proteins in blood are involved in various physiological processes, but their contributions to blood pressure regulation remain partially understood. In traditional observational studies, identifying circulating proteins causally associated with blood pressure is challenging because of potentially unmeasured confounding and possible reverse causality. METHODS: Two-sample Mendelian randomization analyses were conducted to estimate the causal effects of 2270 circulating proteins (data sourced from 8 genome-wide association studies) on diastolic blood pressure, systolic blood pressure, and pulse pressure. Colocalization analyses were then used to investigate whether the circulating proteins and blood pressure traits shared causal genetic variants. To further verify the findings, we subsequently performed Steiger filtering analyses, annotation of protein-altering variants, assessment of overlap between protein quantitative trait loci and expression quantitative trait loci, protein-protein interaction and functional enrichment analyses, and drug target evaluation. To provide more potential biomarkers, we further evaluated the epidemiological associations of 2923 circulating proteins with blood pressure and hypertension by cross-sectional and longitudinal analyses using individual data in the UK Biobank. RESULTS: Mendelian randomization and colocalization analyses identified 121 circulating proteins with putative causal effects on at least 1 blood pressure trait. Many of the identified proteins are enriched in the pathways relevant to blood pressure regulation, and a majority of these proteins are either known drug targets or druggable candidates. CONCLUSIONS: This study has uncovered numerous circulating proteins potentially causally associated with blood pressure, providing insights into the regulatory mechanisms of blood pressure and potential therapeutic targets to facilitate blood pressure management.
- 1 February 2025
- Published by Wolters Kluwer Health in Hypertension
- Vol. 82 (2) , 333-346
Identification of Circulating Proteins Associated With Blood Pressure
BACKGROUND: Circulating proteins in blood are involved in various physiological processes, but their contributions to blood pressure regulation remain partially understood. In traditional observational studies, identifying circulating proteins causally associated with blood pressure is challenging because of potentially unmeasured confounding and possible reverse causality. METHODS: Two-sample Mendelian randomization analyses were conducted to estimate the causal effects of 2270 circulating proteins (data sourced from 8 genome-wide association studies) on diastolic blood pressure, systolic blood pressure, and pulse pressure. Colocalization analyses were then used to investigate whether the circulating proteins and blood pressure traits shared causal genetic variants. To further verify the findings, we subsequently performed Steiger filtering analyses, annotation of protein-altering variants, assessment of overlap between protein quantitative trait loci and expression quantitative trait loci, protein-protein interaction and functional enrichment analyses, and drug target evaluation. To provide more potential biomarkers, we further evaluated the epidemiological associations of 2923 circulating proteins with blood pressure and hypertension by cross-sectional and longitudinal analyses using individual data in the UK Biobank. RESULTS: Mendelian randomization and colocalization analyses identified 121 circulating proteins with putative causal effects on at least 1 blood pressure trait. Many of the identified proteins are enriched in the pathways relevant to blood pressure regulation, and a majority of these proteins are either known drug targets or druggable candidates. CONCLUSIONS: This study has uncovered numerous circulating proteins potentially causally associated with blood pressure, providing insights into the regulatory mechanisms of blood pressure and potential therapeutic targets to facilitate blood pressure management.